Open AccessEfficacy and safety of ursodeoxycholic acid composite on fatigued patients with elevated liver function and/or fatty liver: a multi‐centre, randomised, double‐blinded, placebo‐controlled trial
Author(s) -
Oh B.,
Choi W. S.,
Park S. B.,
Cho B.,
Yang Y. J.,
Lee E. S.,
Lee J. H.
Publication year - 2016
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/ijcp.12790
Subject(s) - medicine , placebo , adverse effect , liver function , visual analogue scale , ursodeoxycholic acid , fatty liver , gastroenterology , liver function tests , randomized controlled trial , clinical endpoint , surgery , disease , pathology , alternative medicine
The aim of this study was to assess the effects of ursodeoxycholic acid composite (URSA-S) on fatigue in patients with elevated liver function tests and/or fatty liver disease.